Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vystar Corporation (VYST)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0032-0.0001 (-3.90%)
At close: 03:48PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0033
Open0.0030
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0030 - 0.0035
52 Week Range0.0030 - 0.0248
Volume546,552
Avg. Volume859,039
Market Cap4.141M
Beta (5Y Monthly)18.45
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for VYST

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VYSTAR CORPORATION
    Analyst Report: Dell Technologies Inc.Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It is focused on premium personal computers and enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell is vertically-integrated but has a robust ecosystem of component and assembly partners, and also relies heavily on channel partners to fulfill its sales.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • GlobeNewswire

    Vystar Adds Vytex into RxAir Spin-off, Sets Spin-Off Record Date, Opens Opportunity for Reverse Merger Into Vystar/Rotmans

    Vystar/Rotmans would have singular focus on furniture/bedding industry to be attractive reverse merger opportunityRxAir NewCo would include RxAir®, Vytex® and Fluid Energy ConversionRxAir NewCo dividend record date set for June 30, 2022After 100% RxAir NewCo spin-off, NewCo will issue 9.5% equity to Vystar Worcester, MA, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) announces that it plans to split into two companies via a dividend. In addition to the previously announced s

  • GlobeNewswire

    Vystar Adds Fluid Energy Conversion Into Planned RxAir Spin-Off

    FEC patented technology has potential for applications in multiple industriesFEC to prioritize air and water purification R&D Worcester, MA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Vystar® Corporation’s (OTCQB: VYST) Board of Directors has approved plans to add its Fluid Energy Conversion, Inc.(FEC), subsidiary into the previously announced planned spin-off of its RxAir® UV light air purification subsidiary into a publicly traded entity (RxAir NewCo). This is expected to occur in early 2022. The addi

Advertisement
Advertisement